NRXP
Price
$1.80
Change
+$0.07 (+4.05%)
Updated
Feb 13 closing price
Capitalization
53.29M
Intraday BUY SELL Signals
VTGN
Price
$0.51
Change
-$0.04 (-7.27%)
Updated
Feb 13 closing price
Capitalization
20.02M
Intraday BUY SELL Signals
Interact to see
Advertisement

NRXP vs VTGN

Header iconNRXP vs VTGN Comparison
Open Charts NRXP vs VTGNBanner chart's image
NRX Pharmaceuticals
Price$1.80
Change+$0.07 (+4.05%)
Volume$261.39K
Capitalization53.29M
VistaGen Therapeutics
Price$0.51
Change-$0.04 (-7.27%)
Volume$3.32M
Capitalization20.02M
NRXP vs VTGN Comparison Chart in %
NRXP
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRXP vs. VTGN commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXP is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (NRXP: $1.80 vs. VTGN: $0.51)
Brand notoriety: NRXP and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXP: 24% vs. VTGN: 95%
Market capitalization -- NRXP: $53.29M vs. VTGN: $20.02M
NRXP [@Biotechnology] is valued at $53.29M. VTGN’s [@Biotechnology] market capitalization is $20.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXP’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • NRXP’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, VTGN is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXP’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • NRXP’s TA Score: 4 bullish, 6 bearish.
  • VTGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than NRXP.

Price Growth

NRXP (@Biotechnology) experienced а -5.76% price change this week, while VTGN (@Biotechnology) price change was -10.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($53.3M) has a higher market cap than VTGN($20M). VTGN YTD gains are higher at: -23.614 vs. NRXP (-33.579). NRXP has higher annual earnings (EBITDA): -38.02M vs. VTGN (-64.79M). VTGN has more cash in the bank: 77.2M vs. NRXP (7.18M). VTGN has less debt than NRXP: VTGN (1.87M) vs NRXP (10.4M). VTGN has higher revenues than NRXP: VTGN (721K) vs NRXP (242K).
NRXPVTGNNRXP / VTGN
Capitalization53.3M20M267%
EBITDA-38.02M-64.79M59%
Gain YTD-33.579-23.614142%
P/E Ratio0.36N/A-
Revenue242K721K34%
Total Cash7.18M77.2M9%
Total Debt10.4M1.87M558%
FUNDAMENTALS RATINGS
NRXP vs VTGN: Fundamental Ratings
NRXP
VTGN
OUTLOOK RATING
1..100
8873
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8796
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (16) in the Biotechnology industry is somewhat better than the same rating for NRXP (55) in the null industry. This means that VTGN’s stock grew somewhat faster than NRXP’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that VTGN’s stock grew similarly to NRXP’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that VTGN’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's Price Growth Rating (87) in the null industry is in the same range as VTGN (96) in the Biotechnology industry. This means that NRXP’s stock grew similarly to VTGN’s over the last 12 months.

NRXP's P/E Growth Rating (94) in the null industry is in the same range as VTGN (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRXPVTGN
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 5 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NRXP
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSAI0.770.16
+26.79%
Cloudastructure Inc
PEBK39.220.72
+1.87%
Peoples Bancorp of North Carolina
IEP8.06-0.02
-0.25%
Icahn Enterprises LP
SE106.74-2.32
-2.13%
Sea Limited
SUPV10.52-0.23
-2.14%
Grupo Supervielle SA

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with NCNA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+4.05%
NCNA - NRXP
85%
Closely correlated
+1.92%
TAOX - NRXP
84%
Closely correlated
+5.91%
PALI - NRXP
74%
Closely correlated
-0.57%
VTGN - NRXP
48%
Loosely correlated
-7.23%
ATRA - NRXP
47%
Loosely correlated
N/A
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been closely correlated with ARTV. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTGN jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-7.23%
ARTV - VTGN
96%
Closely correlated
+0.25%
QNCX - VTGN
91%
Closely correlated
-11.31%
TPST - VTGN
88%
Closely correlated
+2.16%
CALC - VTGN
88%
Closely correlated
-6.41%
MREO - VTGN
87%
Closely correlated
-4.32%
More